Feasibility of CBCT-based dose with a patient-specific stepwise HU-to-density curve to determine time of replanning

作者：Chen Shifeng^*; Le Quynh; Mutaf Yildirim; Lu Wei; Nichols Elizabeth M; Yi Byong Yong; Leven Tish; Prado Karl L; D'Souza Warren D

来源：Journal of Applied Clinical Medical Physics, 2017, 18(5): 64-69.

DOI：10.1002/acm2.12127

• adaptive radiation therapy
• CBCT-based dose calculation
• HU-to-density curve

Purpose: (a) To investigate the accuracy of cone-beam computed tomography (CBCT)-derived dose distributions relative to fanbeam-based simulation CT-derived dose distributions; and (b) to study the feasibility of CBCT dosimetry for guiding the appropriateness of replanning.
Methods and materials: Image data corresponding to 40 patients (10 head and neck [HN], 10 lung, 10 pancreas, 10 pelvis) who underwent radiation therapy were randomly selected. Each patient had both intensity-modulated radiation therapy and volumetric-modulated arc therapy plans; these 80 plans were subsequently recomputed on the CBCT images using a patient-specific stepwise curve (Hounsfield units-to-density). Planning target volumes (PTVs; D98%, D95%, D2%), mean dose, and V95% were compared between simulation-CT-derived treatment plans and CBCT-based plans. Gamma analyses were performed using criterion of 3%/3 mm for three dose zones (>90%, 70%similar to 90%, and 30%similar to 70% of maximum dose). CBCT-derived doses were then used to evaluate the appropriateness of replanning decisions in 12 additional HN patients whose plans were previously revised during radiation therapy because of anatomic changes; replanning in these cases was guided by the conventional observed source-to-skin-distance change-derived approach. R
esults: For all disease sites, the difference in PTV mean dose was 0.1% +/- 1.1%, D2% was 0.7% +/- 0.1%, D95% was 0.2% +/- 1.1%, D98% was 0.2% +/- 1.0%, and V95% was 0.3% +/- 0.8%; For 3D dose comparison, 99.0% +/- 1.9%, 97.6% +/- 4.4%, and 95.3% +/- 6.0% of points passed the 3%/3 mm criterion of gamma analysis in high-, medium-, and low-dose zones, respectively. The CBCT images achieved comparable dose distributions. In the 12 previously replanned 12 HN patients, CBCT-based dose predicted well changes in PTV D2% (Pearson linear correlation coefficient = 0.93; P < 0.001). If 3% of change is used as the replanning criteria, 7/12 patients could avoid replanning.
Conclusions: CBCT-based dose calculations produced accuracy comparable to that of simulation CT. CBCT-based dosimetry can guide the decision to replan during the course of treatment.

• 出版日期2017-9